Furthermore, MM-cells treated with ERK1/2i + CDK4/6i showed dose-dependent significant priming to peptides BAD and HRK, suggesting their dependency on BCL2 and BCL-XL anti-apoptotic proteins. The gene discussed is CDK4; the disease is Miyoshi myopathy.